Effect of Intake of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Blood Cholesterol.
A 12-week, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on Improvement of Blood Cholesterol
1 other identifier
interventional
70
1 country
1
Brief Summary
This study was conducted to investigate the effects of daily supplementation of Citron(Citrus Junos Siebold ex Tanaka) Peel Extract on improvement of Blood Cholesterol.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 28, 2017
CompletedFirst Submitted
Initial submission to the registry
November 2, 2017
CompletedFirst Posted
Study publicly available on registry
November 6, 2017
CompletedNovember 17, 2017
November 1, 2017
4 months
November 2, 2017
November 16, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Changes of Cholesterol
Changes of Cholesterol were assessed before and after the intervention
12 weeks
Secondary Outcomes (2)
Changes of Lipid profile
12 weeks
Changes of Oxidized LDL
12 weeks
Study Arms (2)
Citron peel Extract
EXPERIMENTALCitron peel extract for 12 weeks
Placebo
PLACEBO COMPARATORPlacebo for 12 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Age 19-75 years with Total cholesterol 200-239 mg/dL
You may not qualify if:
- Lipid lowering agent within past 6 months
- Severe cardiovascular disease(Mvodardial infarction, stroke, etc)
- Renal disease(Heredity hyperlipidemia, Acute/Chronic renal failure, Nephrotic syndrome, ect)
- Cancer, Respiratory organ disease(Asthma, Chronic obstructive pulmonary disease)
- Diabetes mellitus
- Allergic or hypersensitive to any of the ingredients in the test products
- History of disease that could interfere with the test products or impede their absorption
- Under antipsychotic drugs therapy within past 2 months
- History of alcohol or substance abuse
- Participation in any other clinical trials within past 2 months
- Laboratory test by show the following results
- Pregnancy or breast feeding
- Not Contraception(except: Surgery for female infertility)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hanyang University
Seoul, 04763, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 2, 2017
First Posted
November 6, 2017
Study Start
June 7, 2017
Primary Completion
September 28, 2017
Study Completion
September 28, 2017
Last Updated
November 17, 2017
Record last verified: 2017-11